Sign in

You're signed outSign in or to get full access.

Amanda Westphal Radcliffe

Director at Vertex
Board

About Amanda Westphal Radcliffe

Amanda Westphal Radcliffe, age 57, has served as a director of Vertex, Inc. since 1993; she previously held roles at the Company spanning technical instruction, finance, production, and middle-market product teams, and earlier was a Managing Director at Rosenbluth International (now part of American Express) . She holds a BA from Moravian University and is a member of the National Association of Corporate Directors (NACD) and the Philadelphia Chapter of Women Corporate Directors, with extensive Company knowledge cited as a core credential for her board service .

Past Roles

OrganizationRoleTenureCommittees/Impact
Vertex, Inc.Various operating roles (technical instructor; finance; production; middle-market product) prior to board servicePre-1993Company operating experience cited as core credential
Rosenbluth International (acquired by American Express)Managing DirectorPrior to VertexCorporate/operational leadership experience

External Roles

OrganizationRoleTenureCommittees/Impact
Neurodiversity Employment Network of PhiladelphiaFounding Member Emeritusn/aAdvocacy/networking leadership
St. Joseph’s University Kinney Center for Autism Education and SupportAdvisory Board Membern/aAdvisory governance
Children’s Hospital of Philadelphia FoundationChair Emeritus, Board of Advisorsn/aNon-profit board leadership
Drexel University A.J. Drexel Autism InstituteChair Emeritus, Boardn/aNon-profit board leadership
Breastcancer.orgChair Emeritusn/aNon-profit board leadership
NACD; Women Corporate Directors (Philadelphia)Membern/aGovernance professional networks

Board Governance

  • Independence: The Board determined Amanda Radcliffe is independent under SEC and Nasdaq rules (six of seven current directors independent) .
  • Committee assignments: Member, Nominating & Governance Committee (Chair: Bradley Gayton); not listed on Audit or Human Capital Committees .
  • Attendance and engagement: The Board met 5 times in 2024; each director attended at least 75% of Board and committee meetings during the period served; all directors attended the 2024 annual meeting; non-employee directors hold regular executive sessions presided over by the Lead Independent Director .
  • Lead Independent Director: Eric Andersen serves as Lead Independent Director .
  • Controlled company context: Parties to the Stockholders’ Agreement (the controlling family group) hold >50% voting power for director elections; Vertex is a “controlled company” under Nasdaq, though the Company states it is not currently relying on controlled-company exemptions .
  • Stockholders’ Agreement governance rights: So long as Amanda Radcliffe (or specified family members/trusts) own ≥5% of outstanding common stock, she is entitled to designate one individual (including herself) for nomination to the Board; Stockholder parties must vote their shares in favor of such nominees; agreement includes transfer restrictions, ROFO/ROFR, registration rights, and a standstill .
  • Dual-class voting mechanics (context): Class A = 1 vote/share; Class B = 10 votes/share; as of record date there were 71,999,335 Class A and 86,480,641 Class B shares outstanding, representing 7.7% and 92.3% of combined voting power, respectively .
  • Related-party transactions: No related party transactions in 2024 (policy requires Audit Committee review/approval for related-party transactions >$120,000) .
  • Human Capital Committee interlocks: None disclosed .

Fixed Compensation

  • Non-employee director program (2024):
    • Annual cash retainer: $42,000; Lead Independent Director/Chair fee: $20,000; Audit Chair: $20,000 (members: $10,000); Human Capital Chair: $15,000 (members: $7,500); Nominating & Governance Chair: $12,000 (members: $6,000) .
    • Annual equity grant at the annual meeting: RSUs with grant-date value of $200,000 (shares = $200,000 divided by closing price; rounds up) .
    • RSUs vest in a single installment on the earlier of the day before the next annual meeting or the first anniversary of grant; accelerated vesting on change in control .
2024 Non-Employee Director Compensation – Amanda W. RadcliffeAmount ($)
Fees Earned or Paid in Cash48,000
Stock Awards (Grant-date fair value)200,017
Total248,017
2024 Director Fee Schedule (Program)Annual Cash Fee ($)
Board Member Retainer42,000
Lead Independent Director or Chair of Board20,000
Audit Committee Chair20,000
Audit Committee Member (non-Chair)10,000
Human Capital Committee Chair15,000
Human Capital Committee Member (non-Chair)7,500
Nominating & Governance Committee Chair12,000
Nominating & Governance Committee Member (non-Chair)6,000

Note: Radcliffe’s $48,000 cash indicates Board retainer ($42,000) plus one committee membership fee ($6,000) for Nominating & Governance .

Performance Compensation

  • Directors receive time-based RSUs (no performance metrics); one-year vest schedule (earlier of day before next annual meeting or first anniversary) and single-trigger acceleration upon change in control .
YearGrant DateShares Granted (#)Grant-Date Fair Value ($)Vesting ScheduleChange-in-Control
20242024-06-125,705 200,017 Single installment at earlier of day before next annual meeting or 1-year anniversary Accelerates immediately prior to change in control
20252025-06-115,327 Same program terms apply (time-based) Accelerates per plan terms

Other Directorships & Interlocks

Company (Public)RoleCommittee RolesNotes
None disclosed in Vertex 2025 ProxyProxy biography lists no other current public company directorships for Radcliffe .

Human Capital Committee interlocks/insider participation: None reported for the committee (applies company-wide) .

Expertise & Qualifications

  • BA, Moravian University; member of NACD and Women Corporate Directors (Philadelphia) .
  • Deep Company knowledge from long tenure and prior operating roles; board qualifications note expertise derived from longstanding service .

Equity Ownership

SecurityBeneficially Owned% of ClassNotes
Class A Common Stock138,065<1%Includes 5,705 unvested restricted stock; sole voting/dispositive power over 53,855; shared voting/dispositive power over 84,210 .
Class B Common Stock33,129,70238.3%Sole voting/dispositive power; Class B carries 10 votes/share .
Combined Voting Power35.4%Voting power percentage attributed to Radcliffe in proxy ownership table .
Options Outstanding (FY-end 2024)No options outstanding; 5,705 restricted stock awards outstanding at FY-end .

Hedging/Pledging: Company policy prohibits directors, officers, and employees (and entities they control) from pledging Company securities or engaging in hedging/monetization transactions (e.g., zero-cost collars, forwards) .

Insider Trades (Form 4) – Transparency Signals

Filing DateTransaction DateTypeSharesPost-Transaction OwnershipLink
2025-06-132025-06-11Award (A)5,327143,392https://www.sec.gov/Archives/edgar/data/1806837/000141588925017195/0001415889-25-017195-index.htm
2024-06-142024-06-12Award (A)5,705138,065https://www.sec.gov/Archives/edgar/data/1806837/000141588924016890/0001415889-24-016890-index.htm

Governance Assessment

Strengths and investor-alignment signals:

  • Independent director with long Company tenure and direct operating experience; member of governance networks (NACD, WCD) .
  • Heavy equity component in director pay (annual $200k time-based RSUs) and formal anti-hedging/anti-pledging policy covering directors .
  • Board practices include regular executive sessions led by an independent lead director; all directors met attendance expectations (≥75%) in 2024 and attended the annual meeting .
  • No related-party transactions in 2024 under Board policy oversight .

Risks and potential red flags:

  • Dual-class structure and Stockholders’ Agreement concentrate voting control for director elections in the controlling family group, potentially reducing responsiveness to minority shareholders (Vertex is a “controlled company” even though it is not currently using exemptions) .
  • Family relationship on the Board (Radcliffe and Thompson are siblings) plus director designation rights under the Stockholders’ Agreement elevate entrenchment risk; the agreement also includes coordinated voting for designated nominees .
  • Significant individual voting influence: Radcliffe beneficially owns 33.13M Class B shares (38.3% of Class B) with combined voting power of 35.4% .

Committee effectiveness and independence:

  • Radcliffe serves on the Nominating & Governance Committee (independent), which oversees director nominations, board evaluations, governance guidelines, ethics/code, and succession planning .
  • The Company states that all three standing committees (Audit, Human Capital, Nominating & Governance) are fully independent; risk oversight (including cybersecurity) is anchored in the Audit Committee .

Compensation structure takeaways (directors):

  • Cash retainer modest relative to equity grant; RSUs are time-based (no performance metrics) with one-year vest and change-in-control acceleration, a common but investor-scrutinized practice for director equity .
  • Company reports it does not provide compensation-related tax gross-ups and maintains stock ownership guidelines for executives and directors (director threshold not quantified in proxy) .

Overall implication for investor confidence:

  • Governance framework demonstrates multiple best practices (committee independence, lead independent director, executive sessions, anti-hedging/pledging, attendance), but the dual-class/Stockholders’ Agreement and family interlocks remain the principal governance risks; investors should weigh the stability and domain knowledge benefits against the entrenchment and reduced minority influence trade-offs .